Stocktoria

MiNK Therapeutics, Inc. INKT

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-15 · LEI

MiNK Therapeutics, Inc. statistics & valuation

Market cap$58.0M
Return on capital-1047.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-127.10% 202020212022202320242025
Shares outstanding
33.5M 33.9M 3.5M 4.0M 4.3M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-356.50% -75.10% -130.40% -493.30% -188.50% -87.70% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.16 -$0.83 -$6.54 -$2.86 -$2.93 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-87.7%-188.5%-493.3%-130.4%-75.1%-356.5%
Return on equity87.8%55.1%124.4%6975.1%-127.1%30.1%
Current ratio1.060.720.321.612.410.29

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.